Background: Chronic pancreatitis is a debilitating condition often accompanied by severe pain. Ultrasound-guided celiac plexus neurolysis (CPN) has emerged as a potential technique for managing this pain. This study aims to evaluate the outcome of ultrasonography (USG) guided CPN in patients with chronic pancreatitis.Methods: This prospective study was conducted from 2022 to 2023, including 10 patients diagnosed with chronic pancreatitis experiencing severe pain. All patients underwent USG-guided CPN. Pain relief was assessed using the Visual Analog Scale (VAS) before the procedure and at 1 week, 1 month, and 3 months post-procedure. Complications were recorded in a data sheet.Results: A significant reduction in VAS scores was observed at all follow-up points compared to baseline. At 1 week, the mean VAS score decreased from 8.5 ± 1.2 to 3.2 ± 1.5 (p<0.001). At 1 month, the mean VAS score further decreased to 2.8 ± 1.3 (p<0.001), and at 3 months, it was 3.5 ± 1.6 (p<0.001). Mild complications, such as transient hypotension and diarrhoea, were reported in a few cases and treated accordingly. No severe complications were observed.Conclusion: USG-guided celiac plexus neurolysis is an effective technique for managing pain in patients with chronic pancreatitis. Further long-term studies are recommended to explore the durability of pain relief.
Hossain et al. (Mon,) studied this question.